The impact of the COVID-19 pandemic on vascular surgery practice in the United States.


Journal

Journal of vascular surgery
ISSN: 1097-6809
Titre abrégé: J Vasc Surg
Pays: United States
ID NLM: 8407742

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 04 06 2020
accepted: 02 08 2020
pubmed: 6 9 2020
medline: 5 3 2021
entrez: 5 9 2020
Statut: ppublish

Résumé

The coronavirus disease 2019 (COVID-19) pandemic has led to widespread postponement and cancelation of elective surgeries in the United States. We designed and administered a global survey to examine the impact of COVID-19 on vascular surgeons. We describe the impact of the pandemic on the practices of vascular surgeons in the United States. The Pandemic Practice, Anxiety, Coping, and Support Survey for Vascular Surgeons is an anonymous cross-sectional survey sponsored by the Society for Vascular Surgery Wellness Task Force disseminated April 14 to 24, 2020. This analysis focuses on pattern changes in vascular surgery practices in the United States including the inpatient setting, ambulatory, and vascular laboratory setting. Specific questions regarding occupational exposure to COVID-19, adequacy of personal protective equipment, elective surgical practice, changes in call schedule, and redeployment to nonvascular surgery duties were also included in the survey. Regional variation was assessed. The survey data were collected using REDCap and analyzed using descriptive statistics. A total of 535 vascular surgeons responded to the survey from 45 states. Most of the respondents were male (73.1%), white (70.7%), practiced in urban settings (81.7%), and in teaching hospitals (66.8%). Almost one-half were in hospitals with more than 400 beds (46.4%). There was no regional variation in the presence of preoperative COVID-19 testing, COVID-19 OR protocols, adherence to national surgical standards, or the availability of personal protective equipment. The overwhelming majority of respondents (91.7%) noted elective surgery cancellation, with the Northeast and Southeast regions having the most case cancellations 94.2% and 95.8%, respectively. The Northeast region reported the highest percentage of operations or procedures on patients with COVID-19, which was either identified at the time of the surgery or later in the hospital course (82.7%). Ambulatory visits were performed via telehealth (81.3%), with 71.1% having restricted hours. More than one-half of office-based laboratories (OBLs) were closed, although there was regional variation with more than 80% in the Midwest being closed. Cases performed in OBLs focused on critical limb ischemia (42.9%) and dialysis access maintenance (39.9%). Call schedules modifications were common, although the number of call days remained the same (45.8%). Vascular surgeons in the United States report substantial impact on their practices during the COVID-19 pandemic, and regional variations are demonstrated, particularly in OBL use, intensive care bed availability, and COVID-19 exposure at work.

Sections du résumé

BACKGROUND BACKGROUND
The coronavirus disease 2019 (COVID-19) pandemic has led to widespread postponement and cancelation of elective surgeries in the United States. We designed and administered a global survey to examine the impact of COVID-19 on vascular surgeons. We describe the impact of the pandemic on the practices of vascular surgeons in the United States.
METHODS METHODS
The Pandemic Practice, Anxiety, Coping, and Support Survey for Vascular Surgeons is an anonymous cross-sectional survey sponsored by the Society for Vascular Surgery Wellness Task Force disseminated April 14 to 24, 2020. This analysis focuses on pattern changes in vascular surgery practices in the United States including the inpatient setting, ambulatory, and vascular laboratory setting. Specific questions regarding occupational exposure to COVID-19, adequacy of personal protective equipment, elective surgical practice, changes in call schedule, and redeployment to nonvascular surgery duties were also included in the survey. Regional variation was assessed. The survey data were collected using REDCap and analyzed using descriptive statistics.
RESULTS RESULTS
A total of 535 vascular surgeons responded to the survey from 45 states. Most of the respondents were male (73.1%), white (70.7%), practiced in urban settings (81.7%), and in teaching hospitals (66.8%). Almost one-half were in hospitals with more than 400 beds (46.4%). There was no regional variation in the presence of preoperative COVID-19 testing, COVID-19 OR protocols, adherence to national surgical standards, or the availability of personal protective equipment. The overwhelming majority of respondents (91.7%) noted elective surgery cancellation, with the Northeast and Southeast regions having the most case cancellations 94.2% and 95.8%, respectively. The Northeast region reported the highest percentage of operations or procedures on patients with COVID-19, which was either identified at the time of the surgery or later in the hospital course (82.7%). Ambulatory visits were performed via telehealth (81.3%), with 71.1% having restricted hours. More than one-half of office-based laboratories (OBLs) were closed, although there was regional variation with more than 80% in the Midwest being closed. Cases performed in OBLs focused on critical limb ischemia (42.9%) and dialysis access maintenance (39.9%). Call schedules modifications were common, although the number of call days remained the same (45.8%).
CONCLUSIONS CONCLUSIONS
Vascular surgeons in the United States report substantial impact on their practices during the COVID-19 pandemic, and regional variations are demonstrated, particularly in OBL use, intensive care bed availability, and COVID-19 exposure at work.

Identifiants

pubmed: 32889073
pii: S0741-5214(20)31920-0
doi: 10.1016/j.jvs.2020.08.036
pmc: PMC7462594
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

772-779.e4

Informations de copyright

Copyright © 2020 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Foot Ankle Int. 2020 Jul;41(7):881-884
pubmed: 32450723
N Engl J Med. 2020 May 7;382(19):e52
pubmed: 32329973
World Neurosurg. 2020 Jul;139:e818-e826
pubmed: 32380337
Br J Surg. 2020 Jul;107(8):e246
pubmed: 32410222
J Vasc Surg. 2020 Jul;72(1):379-380
pubmed: 32334050
Patient Saf Surg. 2020 Mar 31;14:8
pubmed: 32288785
J Vasc Surg. 2020 Aug;72(2):396-402
pubmed: 32361072
J Visc Surg. 2020 Jun;157(3S1):S7-S12
pubmed: 32249098
Br J Surg. 2020 Oct;107(11):1440-1449
pubmed: 32395848
J Am Coll Surg. 2020 Jun;230(6):1080-1091.e3
pubmed: 32240770
Ophthalmology. 2020 Aug;127(8):e51-e52
pubmed: 32359842
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Obes Surg. 2020 Sep;30(9):3624-3627
pubmed: 32314249
J Vasc Surg. 2020 Aug;72(2):391-392
pubmed: 32360373

Auteurs

Nicolas J Mouawad (NJ)

Division of Vascular & Endovascular Surgery, McLaren Health System, Bay City, Mich; Division of Vascular Surgery, Michigan State University, Lansing, Mich.

Karen Woo (K)

Division of Vascular Surgery, University of California Los Angeles, Los Angeles, Calif.

Rafael D Malgor (RD)

Division of Vascular Surgery and Endovascular Therapy, The University of Colorado, Anschutz Medical Center, Aurora, Colo.

Max V Wohlauer (MV)

Division of Vascular Surgery and Endovascular Therapy, The University of Colorado, Anschutz Medical Center, Aurora, Colo.

Adam P Johnson (AP)

New York/Presbyterian Weill Cornell School of Medicine, New York, NY.

Robert F Cuff (RF)

Vascular Surgery, Spectrum Health Medical Group, Grand Rapids, Mich.

Dawn M Coleman (DM)

Department of Surgery, University of Michigan, Ann Arbor, Mich.

Sheila M Coogan (SM)

Department of Cardiovascular Surgery, University of Texas at Houston, Houston, Tex.

Malachi G Sheahan (MG)

Division of Vascular and Endovascular Surgery, Louisiana State University Health Sciences Center, New Orleans, La.

Sherene Shalhub (S)

Division of Vascular Surgery, Department of Surgery, University of Washington, Seattle, Wash. Electronic address: shalhub@uw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH